Handel AstraZeneca PLC - GBP - AZNl CFD
Føj til favorit- Opsummering
- Historisk Data
- Begivenheder
- Resultatopgørelse
- Saldo
- Cash flow
- Ejerskab
Spænd | 0.26 | ||||||||
Long position, gebyr natten over
Long position overnight fee
Gå til platform | -0.023178% | ||||||||
Short position, gebyr natten over
Short position overnight fee
Gå til platform | 0.00126% | ||||||||
Gebyr natten over, tid | 21:00 (UTC) | ||||||||
Min. handlet mængde | 1 | ||||||||
Valuta | GBP | ||||||||
Margen | 20% | ||||||||
Aktiebørs | United Kingdom of Great Britain and Northern Ireland | ||||||||
Kommission på handel | 0% |
*Information provided by Capital.com
AstraZeneca PLC ESG Risk Ratings
‘A’ score indicates excellent relative ESG performance and high degree of transparency in reporting material ESG data publicly
Tidligere luk* | 116.78 |
Åben* | 115.68 |
1-Års Ændring* | 10.79% |
Dagens Spænd* | 115.68 - 116.12 |
52-Ugers Spænd | 93.99-128.29 |
Gennemsnitlig Volumen (10 dage) | 1.37M |
Gennemsnitlig Volumen (3 måneder) | 32.47M |
Market Cap | 179.60B |
P/E-forhold | 48.12 |
Udestående aktier | 1.55B |
Omsætning | 35.00B |
EPS | 2.41 |
Dividend (Udbytte %) | 2.0497 |
Beta | 0.26 |
Næste indtjeningsopgørelse | Jul 28, 2023 |
Al data kommer fra Refinitiv, med undtagelse af data markeret med en asterisk, som er *data fra Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Luk | Change | Change (%) | Åben | High | Low |
---|---|---|---|---|---|---|
May 31, 2023 | 116.78 | 2.22 | 1.94% | 114.56 | 117.54 | 114.30 |
May 30, 2023 | 113.22 | -4.28 | -3.64% | 117.50 | 118.28 | 113.22 |
May 26, 2023 | 116.62 | -0.10 | -0.09% | 116.72 | 118.18 | 116.10 |
May 25, 2023 | 116.08 | -0.70 | -0.60% | 116.78 | 118.08 | 115.64 |
May 24, 2023 | 116.34 | -2.04 | -1.72% | 118.38 | 119.14 | 116.34 |
May 23, 2023 | 119.79 | 0.42 | 0.35% | 119.37 | 121.71 | 118.86 |
May 22, 2023 | 119.77 | 0.22 | 0.18% | 119.55 | 120.95 | 119.55 |
May 19, 2023 | 120.21 | 0.62 | 0.52% | 119.59 | 120.61 | 119.22 |
May 18, 2023 | 119.60 | 0.11 | 0.09% | 119.49 | 120.83 | 119.49 |
May 17, 2023 | 118.62 | -2.43 | -2.01% | 121.05 | 121.69 | 118.50 |
May 16, 2023 | 120.31 | 1.10 | 0.92% | 119.21 | 120.89 | 119.21 |
May 15, 2023 | 119.80 | -0.21 | -0.17% | 120.01 | 120.49 | 119.58 |
May 12, 2023 | 119.72 | 0.56 | 0.47% | 119.16 | 120.75 | 119.06 |
May 11, 2023 | 119.12 | 0.44 | 0.37% | 118.68 | 119.87 | 118.52 |
May 10, 2023 | 117.98 | 0.00 | 0.00% | 117.98 | 118.64 | 116.92 |
May 9, 2023 | 118.74 | 1.22 | 1.04% | 117.52 | 119.28 | 117.52 |
May 5, 2023 | 118.92 | 0.90 | 0.76% | 118.02 | 118.94 | 116.98 |
May 4, 2023 | 118.34 | 0.02 | 0.02% | 118.32 | 118.66 | 117.42 |
May 3, 2023 | 118.68 | 0.24 | 0.20% | 118.44 | 118.92 | 117.66 |
May 2, 2023 | 117.74 | -0.02 | -0.02% | 117.76 | 118.42 | 116.74 |
AstraZeneca PLC - GBP Events
Tid (UTC) (UTC) | Land | Begivenhed |
---|---|---|
Monday, June 5, 2023 | ||
Tid (UTC) (UTC) 23:00 | Land GB
| Begivenhed AstraZeneca PLC at ASCO Investor Meeting (Virtual) AstraZeneca PLC at ASCO Investor Meeting (Virtual)Forecast -Previous - |
- Årlig
- Pr kvartal
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total omsætning | 44351 | 37417 | 26617 | 24384 | 22090 |
Omsætning | 44351 | 37417 | 26617 | 24384 | 22090 |
Kost af omsætning, Total | 8649 | 9542 | 5270 | 4824 | 4246 |
Bruttofortjeneste | 35702 | 27875 | 21347 | 19560 | 17844 |
Totale Driftsudgifter | 40594 | 36361 | 21455 | 21460 | 18703 |
Salgs/Generelle/Admin. Udgifter, Total | 13512 | 11519 | 9338 | 8964 | 8479 |
Forskning & Udvikling | 9612 | 8519 | 6094 | 5320 | 5266 |
Depreciation / Amortization | 4094 | 3044 | 1897 | 1812 | 1945 |
Usædvanlig Udgift (Indkomst) | 4820 | 3846 | -763 | 863 | -953 |
Other Operating Expenses, Total | -93 | -109 | -381 | -323 | -280 |
Driftsindtægter | 3757 | 1056 | 5162 | 2924 | 3387 |
Renteindkomst (Udgift), Netto Ikke-Drift | -815 | -819 | -716 | -766 | -775 |
Andre, Netto | -441 | -502 | -530 | -610 | -619 |
Netto Indkomst Før Skat | 2501 | -265 | 3916 | 1548 | 1993 |
Netto Indkomst Efter Skat | 3293 | 115 | 3144 | 1227 | 2050 |
Minoritetsrente | -5 | -3 | 52 | 108 | 105 |
Netto Indkomst Før Ekstra Ting | 3288 | 112 | 3196 | 1335 | 2155 |
Netto Indkomst | 3288 | 112 | 3196 | 1335 | 2155 |
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting | 3288 | 112 | 3196 | 1335 | 2155 |
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting | 3288 | 112 | 3196 | 1335 | 2155 |
Fortyndelsesændring | 0 | 0 | |||
Fortyndet Netto Indkomst | 3288 | 112 | 3196 | 1335 | 2155 |
Fortyndet Vægtet Gennemsnit Aktier | 1560 | 1427 | 1313 | 1301 | 1267 |
Fortyndet EPS Uden Ekstraordinære Ting | 2.10769 | 0.07849 | 2.43412 | 1.02613 | 1.70087 |
Dividends per Share - Common Stock Primary Issue | 2.89361 | 2.84245 | 2.83031 | 2.89446 | 2.74532 |
Fortyndet Normaliseret EPS | 3.8859 | 2.22705 | 1.88804 | 1.48501 | 0.85399 |
Renteudgift (Indkomst) - Netto Drift | 0 | 0 | |||
Totale Ekstraordinære Ting |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Total omsætning | 10879 | 11207 | 10982 | 10771 | 11390 |
Omsætning | 10879 | 11207 | 10982 | 10771 | 11390 |
Kost af omsætning, Total | 2053 | 2417 | 2118 | 1904 | 2279 |
Bruttofortjeneste | 8826 | 8790 | 8864 | 8867 | 9111 |
Totale Driftsudgifter | 8330 | 10113 | 9737 | 10232 | 10512 |
Salgs/Generelle/Admin. Udgifter, Total | 3196 | 3469 | 3353 | 3633 | 3057 |
Forskning & Udvikling | 2299 | 2638 | 2357 | 2431 | 2186 |
Depreciation / Amortization | 954 | 1034 | 979 | 983 | 1098 |
Usædvanlig Udgift (Indkomst) | 230 | 331 | 1002 | 1298 | 1953 |
Other Operating Expenses, Total | -402 | 224 | -72 | -17 | -61 |
Driftsindtægter | 2549 | 1094 | 1245 | 539 | 878 |
Renteindkomst (Udgift), Netto Ikke-Drift | -287 | -316 | -323 | -292 | -325 |
Netto Indkomst Før Skat | 2262 | 778 | 922 | 247 | 553 |
Netto Indkomst Efter Skat | 1804 | 902 | 1642 | 360 | 388 |
Minoritetsrente | -1 | -1 | -2 | 0 | -2 |
Netto Indkomst Før Ekstra Ting | 1803 | 901 | 1640 | 360 | 386 |
Netto Indkomst | 1803 | 901 | 1640 | 360 | 386 |
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting | 1803 | 901 | 1640 | 360 | 386 |
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting | 1803 | 901 | 1640 | 360 | 386 |
Fortyndelsesændring | |||||
Fortyndet Netto Indkomst | 1803 | 901 | 1640 | 360 | 386 |
Fortyndet Vægtet Gennemsnit Aktier | 1560 | 1560 | 1559 | 1560 | 1561 |
Fortyndet EPS Uden Ekstraordinære Ting | 1.15577 | 0.57756 | 1.05196 | 0.23077 | 0.24728 |
Dividends per Share - Common Stock Primary Issue | 0 | 1.9694 | 0 | 0.93017 | 0 |
Fortyndet Normaliseret EPS | 1.27335 | 0.70833 | 0.99743 | 0.80833 | 1.24792 |
- Årlig
- Pr kvartal
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Totale Nuværende Aktiver | 22593 | 26244 | 19544 | 15563 | 15591 |
Likvider og Kortsigtede Investeringer | 6405 | 6398 | 7992 | 6218 | 5680 |
Cash | 1411 | 1461 | 1182 | 755 | 893 |
Likvider & Lignende | 4755 | 4868 | 6650 | 4614 | 3938 |
Kortsigtede Investeringer | 239 | 69 | 160 | 849 | 849 |
Totale Tilgodehavender, Netto | 9923 | 8795 | 5651 | 5181 | 4345 |
Accounts Receivable - Trade, Net | 7508 | 6324 | 3956 | 3813 | 2995 |
Total Inventory | 4699 | 8983 | 4024 | 3193 | 2890 |
Prepaid Expenses | 1329 | 1512 | 1735 | 865 | 1436 |
Other Current Assets, Total | 237 | 556 | 142 | 106 | 1240 |
Total Assets | 96483 | 105363 | 66729 | 61377 | 60651 |
Property/Plant/Equipment, Total - Net | 9449 | 10171 | 8917 | 8335 | 7421 |
Property/Plant/Equipment, Total - Gross | 17192 | 18495 | 17110 | 15852 | 14639 |
Accumulated Depreciation, Total | -7743 | -8324 | -8193 | -7517 | -7218 |
Goodwill, Net | 19820 | 19997 | 11845 | 11668 | 11707 |
Intangibles, Net | 39307 | 42387 | 20947 | 20833 | 21959 |
Long Term Investments | 1142 | 1237 | 1147 | 1459 | 922 |
Note Receivable - Long Term | 592 | 504 | 325 | 348 | 515 |
Other Long Term Assets, Total | 3580 | 4823 | 4004 | 3171 | 2536 |
Total Current Liabilities | 26293 | 22594 | 20307 | 18117 | 16292 |
Accounts Payable | 2550 | 2824 | 2350 | 1774 | 1720 |
Accrued Expenses | 8303 | 8079 | 4994 | 5085 | 5148 |
Notes Payable/Short Term Debt | 261 | 294 | 370 | 154 | 160 |
Current Port. of LT Debt/Capital Leases | 5281 | 1599 | 2016 | 1856 | 1594 |
Other Current Liabilities, Total | 9898 | 9798 | 10577 | 9248 | 7670 |
Total Liabilities | 59446 | 66095 | 51107 | 48250 | 48183 |
Total Long Term Debt | 23690 | 28888 | 17994 | 16217 | 17359 |
Long Term Debt | 22965 | 28134 | 17505 | 15730 | 17359 |
Capital Lease Obligations | 725 | 754 | 489 | 487 | 0 |
Deferred Income Tax | 2944 | 6206 | 2918 | 2490 | 3286 |
Minority Interest | 21 | 19 | 16 | 1469 | 1576 |
Other Liabilities, Total | 6498 | 8388 | 9872 | 9957 | 9670 |
Total Equity | 37037 | 39268 | 15622 | 13127 | 12468 |
Common Stock | 387 | 387 | 328 | 328 | 317 |
Additional Paid-In Capital | 35155 | 35126 | 7971 | 7941 | 4427 |
Retained Earnings (Accumulated Deficit) | 1495 | 3755 | 7323 | 4858 | 7724 |
Total Liabilities & Shareholders’ Equity | 96483 | 105363 | 66729 | 61377 | 60651 |
Total Common Shares Outstanding | 1549.8 | 1549.4 | 1312.67 | 1312.14 | 1267.04 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Totale Nuværende Aktiver | 22266 | 22593 | 20224 | 20917 | 22647 |
Likvider og Kortsigtede Investeringer | 6462 | 6405 | 4898 | 4887 | 5823 |
Likvider & Lignende | 6232 | 6166 | 4458 | 4817 | 5762 |
Kortsigtede Investeringer | 230 | 239 | 440 | 70 | 61 |
Totale Tilgodehavender, Netto | 10797 | 11252 | 10061 | 9612 | 9050 |
Accounts Receivable - Trade, Net | 10289 | 10521 | 9336 | 8908 | 8683 |
Total Inventory | 4967 | 4699 | 5078 | 6220 | 7624 |
Other Current Assets, Total | 40 | 237 | 187 | 198 | 150 |
Total Assets | 96687 | 96483 | 94185 | 96579 | 100273 |
Property/Plant/Equipment, Total - Net | 9599 | 9449 | 9227 | 9627 | 10015 |
Goodwill, Net | 20001 | 19820 | 19707 | 19821 | 19963 |
Intangibles, Net | 39291 | 39307 | 39585 | 39900 | 41265 |
Long Term Investments | 1234 | 1142 | 1102 | 1180 | 1237 |
Note Receivable - Long Term | 682 | 835 | 792 | 881 | 864 |
Other Long Term Assets, Total | 3614 | 3337 | 3548 | 4253 | 4282 |
Total Current Liabilities | 24860 | 26293 | 24850 | 21815 | 22740 |
Payable/Accrued | 19210 | 19040 | 17694 | 17821 | 17864 |
Notes Payable/Short Term Debt | 568 | 261 | 584 | 636 | 724 |
Current Port. of LT Debt/Capital Leases | 3289 | 5281 | 5034 | 1746 | 1570 |
Other Current Liabilities, Total | 1793 | 1711 | 1538 | 1612 | 2582 |
Total Liabilities | 60898 | 59446 | 59051 | 60647 | 63933 |
Total Long Term Debt | 27646 | 23690 | 23681 | 27146 | 28805 |
Long Term Debt | 26916 | 22965 | 23013 | 26461 | 28081 |
Capital Lease Obligations | 730 | 725 | 668 | 685 | 724 |
Deferred Income Tax | 2795 | 2944 | 3479 | 5275 | 5626 |
Minority Interest | 22 | 21 | 20 | 19 | 19 |
Other Liabilities, Total | 5575 | 6498 | 7021 | 6392 | 6743 |
Total Equity | 35789 | 37037 | 35134 | 35932 | 36340 |
Common Stock | 387 | 387 | 387 | 387 | 387 |
Additional Paid-In Capital | 35159 | 35155 | 35137 | 35134 | 35131 |
Retained Earnings (Accumulated Deficit) | 243 | 1495 | -390 | 411 | 822 |
Total Liabilities & Shareholders’ Equity | 96687 | 96483 | 94185 | 96579 | 100273 |
Total Common Shares Outstanding | 1549.85 | 1549.8 | 1549.51 | 1549.48 | 1549.45 |
- Årlig
- Pr kvartal
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Netto indkomst/Startlinje | 2501 | -265 | 3916 | 1548 | 1993 |
Likvider Fra Driftsaktiviteter | 9808 | 5963 | 4799 | 2969 | 2618 |
Likvider Fra Driftsaktiviteter | 5480 | 6530 | 3149 | 3762 | 3753 |
Ikke-Likvide Ting | 542 | 141 | -332 | -103 | -1276 |
Cash Taxes Paid | 1623 | 1743 | 1562 | 1118 | 537 |
Likvid Rente Betalt | 849 | 721 | 733 | 774 | 676 |
Ændringer i Driftskapital | 1285 | -443 | -1934 | -2238 | -1852 |
Likvider fra Investeringsaktiviteter | -2960 | -11058 | -285 | -657 | 963 |
Kapitaludgifter | -2571 | -2200 | -2606 | -2460 | -1371 |
Andre Investerings-Cash-Flow-Ting, Total | -389 | -8858 | 2321 | 1803 | 2334 |
Likvider fra Financieringsaktiviteter | -6823 | 3649 | -2203 | -1765 | -2044 |
Financiering af Cash-Flow-Ting | -1047 | -178 | -101 | 4 | -67 |
Total Cash Dividends Paid | -4364 | -3856 | -3572 | -3592 | -3484 |
Udstedelse (Pensionering) af Aktier, Netto | 29 | 29 | 30 | 3525 | 34 |
Udstedelse (Pensionering) af Gæld, Netto | -1441 | 7654 | 1440 | -1702 | 1473 |
Udenlandsk Børs Effekter | -80 | -62 | 12 | 5 | -38 |
Netto Ændring i Likviditet | -55 | -1508 | 2323 | 552 | 1499 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | 2262 | 2501 | 1723 | 800 | 553 |
Cash From Operating Activities | 3133 | 9808 | 7410 | 4480 | 3232 |
Cash From Operating Activities | 1502 | 5480 | 4000 | 2666 | 1309 |
Non-Cash Items | -391 | 542 | 172 | 15 | -12 |
Cash Taxes Paid | 225 | 1623 | 1335 | 1006 | 228 |
Cash Interest Paid | 257 | 849 | 608 | 386 | 194 |
Changes in Working Capital | -240 | 1285 | 1515 | 999 | 1382 |
Cash From Investing Activities | -1246 | -2960 | -2711 | -968 | -168 |
Capital Expenditures | -1470 | -2571 | -2017 | -906 | -363 |
Other Investing Cash Flow Items, Total | 224 | -389 | -694 | -62 | 195 |
Cash From Financing Activities | -2031 | -6823 | -6465 | -5035 | -3740 |
Financing Cash Flow Items | -840 | -1047 | -1047 | -997 | -997 |
Total Cash Dividends Paid | -3047 | -4364 | -4364 | -2971 | -2971 |
Issuance (Retirement) of Stock, Net | 4 | 29 | 11 | 8 | 5 |
Issuance (Retirement) of Debt, Net | 1852 | -1441 | -1065 | -1075 | 223 |
Foreign Exchange Effects | -11 | -80 | -86 | -35 | -9 |
Net Change in Cash | -155 | -55 | -1852 | -1558 | -685 |
Investornavn | Investortype | Procent udestående | Aktiebeholdning | Aktieændring | Beholdningsdato | IOmsætningsscore |
---|---|---|---|---|---|---|
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 6.5098 | 100893184 | 1200 | 2023-01-31 | LOW |
Wellington Management Company, LLP | Investment Advisor/Hedge Fund | 4.1999 | 65092368 | 768 | 2023-01-31 | LOW |
Capital Research Global Investors | Investment Advisor | 4.1199 | 63852512 | 752 | 2023-01-31 | LOW |
Investor AB | Private Equity | 3.3299 | 51608948 | 608 | 2023-01-31 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 2.8464 | 44114976 | -1215991 | 2022-12-14 | LOW |
Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 2.2269 | 34514808 | 15209 | 2023-05-01 | LOW |
Capital World Investors | Investment Advisor | 1.7648 | 27351981 | 2675871 | 2022-12-14 | LOW |
BlackRock Advisors (UK) Limited | Investment Advisor/Hedge Fund | 1.2141 | 18816198 | 280706 | 2023-05-01 | LOW |
BlackRock Investment Management (UK) Ltd. | Investment Advisor/Hedge Fund | 1.1273 | 17471628 | -78807 | 2023-05-01 | LOW |
GQG Partners, LLC | Investment Advisor | 1.0697 | 16579162 | 1036509 | 2022-12-14 | MED |
Legal & General Investment Management Ltd. | Investment Advisor/Hedge Fund | 0.9835 | 15243057 | -36818 | 2023-05-01 | LOW |
State Street Global Advisors (UK) Ltd. | Investment Advisor/Hedge Fund | 0.6302 | 9767199 | -6522 | 2023-05-01 | LOW |
Nuveen LLC | Pension Fund | 0.6158 | 9543355 | 495683 | 2022-12-14 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.5411 | 8386244 | -95567 | 2022-12-14 | LOW |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 0.4985 | 7725827 | -10523 | 2023-05-01 | LOW |
Handelsbanken Kapitalförvaltning AB | Investment Advisor/Hedge Fund | 0.4931 | 7642032 | 181760 | 2023-04-30 | LOW |
Aviva Investors Global Services Limited | Investment Advisor/Hedge Fund | 0.4919 | 7623953 | -442236 | 2023-05-01 | LOW |
M & G Investment Management Ltd. | Investment Advisor | 0.4722 | 7318503 | -220395 | 2023-05-01 | LOW |
Fidelity Management & Research Company LLC | Investment Advisor | 0.4707 | 7294740 | 0 | 2023-05-01 | LOW |
BlackRock Investment Management, LLC | Investment Advisor/Hedge Fund | 0.4379 | 6787247 | -85660 | 2023-03-31 | LOW |
Hvorfor vælge Capital.com? Vores tal taler for sig selv.
Capital.com Group535K+
Handlende
87K+
Månedlkige, aktive klienter
$113M+
Månedlig investeringsvolumen
$64M+
Hævet hver måned
Handelslommeregner
Udregn dit hypotetiske P&L hvis du havde åbnet en CFD-handel på en given dato (vælg en dato) og lukket den på en anden dato (vælg en dato).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
AstraZeneca - GBP Company profile
Om AstraZeneca PLC - GBP
AstraZeneca PLC (AstraZeneca) er en patientfokuseret biofarmaceutisk virksomhed. Virksomheden fokuserer på opdagelse og udvikling, fremstilling og markedsføring af receptpligtige lægemidler, primært til behandling af sygdomme. Selskabet er fokuseret på tre hovedterapiområder: Onkologi; kardiovaskulær, renal og metabolisme samt respiratorisk og immunologi. Virksomhedens pipeline består af en solid portefølje af behandlinger på forskellige stadier af klinisk udvikling. Selskabet har adgang til teknologier, både internt og gennem sine forskellige samarbejdsaftaler. Dens teknologier omfatter akustisk rørteknologi, avanceret molekylær billeddannelse, kryo-elektronmikroskopi (kryo-EM), funktionel genomik, multi-omik og AstraZeneca iLab. Selskabets teknologi med akustiske rør hjælper det til at håndtere og behandle millioner af forbindelser til biologisk screening. AstraZeneca iLab er virksomhedens prototype på et automatiseret medicinalkemisk laboratorium.
Industry: | Pharmaceuticals (NEC) |
1 Francis Crick Avenue
CAMBRIDGE
CAMBRIDGESHIRE CB2 0AA
GB
Resultatopgørelse
- Annual
- Quarterly
Folk ser også
Leder du stadig efter en mægler, du kan stole på?
Deltag sammen med 535.000+ handlende over hele verden, der valgte at handle hos Capital.com